• 1
    Dougados M. It's good to feel better but it's better to feel good [editorial]. J Rheumatol 2005; 32: 12.
  • 2
    Anderson JJ, Baron G, van der Heijde D, Felson DT, Dougados M. Ankylosing Spondylitis Assessment Group preliminary definition of short-term improvement in ankylosing spondylitis. Arthritis Rheum 2001; 44: 187686.
  • 3
    Wells G, Boers M, Shea B, Brooks PM, Simon LS, Strand CV, et al. Minimal disease activity for rheumatoid arthritis: a preliminary definition. J Rheumatol 2005; 32: 201624.
  • 4
    Tubach F, Wells GA, Ravaud P, Dougados M. Minimal clinically important difference, low disease activity state, and patient acceptable symptom state: methodological issues. J Rheumatol 2005; 32: 20259.
  • 5
    Maksymowych WP, Richardson R, Mallon C, van der Heijde D, Boonen A. Evaluation and validation of the patient acceptable symptom state (PASS) in patients with ankylosing spondylitis. Arthritis Rheum 2007; 57: 1339.
  • 6
    Dougados M, Luo MP, Maksymowych WP, Chmiel JJ, Chen N, Wong RL, et al, for the ATLAS Study Group. Evaluation of the patient acceptable symptom state as an outcome measure in patients with ankylosing spondylitis: data from a randomized controlled trial. Arthritis Rheum 2008; 59: 55360.
  • 7
    Tubach F, Pham T, Skomsvoll JF, Mikkelsen K, Bjorneboe O, Ravaud P, et al. Stability of the patient acceptable symptomatic state over time in outcome criteria in ankylosing spondylitis. Arthritis Rheum 2006; 55: 9603.
  • 8
    Cohen JD, Cunin P, Farrenq V, Oniankitan O, Carton L, Chevalier X, et al. Estimation of the Bath Ankylosing Spondylitis Disease Activity Index cutoff for perceived symptom relief in patients with spondyloarthropathies. J Rheumatol 2006; 33: 7981.
  • 9
    Tubach F, Ravaud P, Baron G, Falissard B, Logeart I, Bellamy N, et al. Evaluation of clinically relevant states in patient-reported outcomes in knee and hip osteoarthritis: the patient acceptable symptom state. Ann Rheum Dis 2005; 64: 347.
  • 10
    Van der Heijde D, Kivitz A, Schiff MH, Sieper J, Dijkmans BA, Braun J, et al. Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2006; 54: 213646.
  • 11
    Van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. Arthritis Rheum 1984; 27: 3618.
  • 12
    Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994; 21: 228691.
  • 13
    Doward LC, Spoorenberg A, Cook SA, Whalley D, Helliwell PS, Kay LJ, et al. Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis. Ann Rheum Dis 2003; 62: 206.
  • 14
    Calin A, Garrett S, Whitelock H, Kennedy LG, O'Hea J, Mallorie P, et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 1994; 21: 22815.
  • 15
    Tubach F, Ravaud P, Beaton D, Boers M, Bombardier C, Felson D, et al. OMERACT 8 Special Interest Group: minimal clinically important improvement and patient acceptable symptom state for subjective outcome measures in the rheumatic disorders. J Rheumatol 2007; 34: 118893.
  • 16
    Scott NW, Fayers PM, Aaronson NK, Bottomley A, de Graeff A, Groenvold M, et al, and the EORTC Quality of Life Group and Quality of Life Cross-Cultural Meta-Analysis Group. The relationship between overall quality of life and its subdimensions was influenced by culture: analysis of an international database. J Clin Epidemiol 2008; 61: 78895.
  • 17
    Bodian CA, Freedman G, Hossain S, Eisenkraft JB, Beilin Y. The visual analog scale for pain: clinical significance in postoperative patients. Anesthesiology 2001; 95: 135661.
  • 18
    Sofaer B, Moore AP, Holloway I, Lamberty JM, Thorp TA, O'Dwyer J. Chronic pain as perceived by older people: a qualitative study. Age Ageing 2005; 34: 4626.
  • 19
    Pool GJ, Schwegler AF, Theodore BR, Fuchs PN. Role of gender norms and group identification on hypothetical and experimental pain tolerance. Pain 2007; 129: 1229.
  • 20
    Taylor AL, Balakrishnan C, Calin A. Reference centile charts for measures of disease activity, functional impairment, and metrology in ankylosing spondylitis. Arthritis Rheum 1998; 41: 111925.
  • 21
    Claudepierre P, Sibilia J, Roudot-Thoraval F, Flipo RM, Wendling D, Goupille P, et al. Factors linked to disease activity in a French cohort of patients with spondyloarthropathy. J Rheumatol 1998; 25: 192731.
  • 22
    Weisse CS, Kemoy K, Foster KK, Fisher EA. The influence of experimenter gender and race on pain reporting: does racial or gender concordance matter? Pain Med 2005; 6: 807.
  • 23
    Holdcroft A. Integrating the dimensions of sex and gender into basic life sciences research: methodologic and ethical issues. Gender Med 2007; 4 Suppl: S6474.
  • 24
    Sprangers MA, Schwartz CE. The challenge of response shift for quality-of-life-based clinical oncology research. Ann Oncol 1999; 10: 7479.
  • 25
    Schwartz CE, Sprangers MA. Methodological approaches for assessing response shift in longitudinal health-related quality-of-life research. Soc Sci Med 1999; 48: 153148.
  • 26
    Norman G. Hi! How are you? Response shift, implicit theories and differing epistemologies. Qual Life Res 2003; 12: 23949.
  • 27
    Visser MR, Smets EM, Sprangers MA, de Haes HJ. How response shift may affect the measurement of change in fatigue. J Pain Symptom Manage 2000; 20: 128.
  • 28
    Bernhard J, Hurny C, Maibach R, Herrmann R, Laffer U, and the Swiss Group for Clinical Cancer Research (SAKK). Quality-of-life as subjective experience: reframing of perception in patients with colon cancer undergoing radical resection with or without adjuvant chemotherapy. Ann Oncol 1999; 10: 77582.
  • 29
    Schwartz CE, Bode R, Repucci N, Becker J, Sprangers MA, Fayers PM. The clinical significance of adaptation to changing health: a meta-analysis of response shift. Qual Life Res 2006; 15: 153350.
  • 30
    Gallo JJ, Rabins PV. Depression without sadness: alternative presentations of depression in late life. Am Fam Physician 1999; 60: 8206.
  • 31
    Rasch G. Probabilistic models for some intelligence and attainment tests. Copenhagen (Denmark): Danish Institute of Educational Research; 1960.